Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEK162 in NRAS-Mutated Metastatic Melanoma With Brain Metastases
DRKS00009626Phase 2Recruiting
- Sponsor
- University Hospital Zurich
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of binimetinib in cutaneous melanoma (CM), sponsored by University Hospital Zurich. Started Nov 2015; status: recruiting.
02
Drugs
binimetinib
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on DRKS00009626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009626.